SPY411.49+2.97 0.73%
DIA337.86+2.73 0.81%
IXIC13,900.19+70.88 0.51%

--Analyst Actions: RBC Cuts Price Target on Osmotica Pharmaceuticals to $8 From $12, Maintains Outperform-Speculative Risk Rating

· 03/17/2021 04:22

Please log in to view news